enGene Holdings Inc. (NASDAQ: ENGN) Stock Information | RedChip

enGene Holdings Inc. (NASDAQ: ENGN) Listen to this Section


$5.75
-0.1500 ( -2.54% ) 10.9K

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Market Data


Open


$5.75

Previous close


$5.90

Volume


10.9K

Market cap


$268.97M

Day range


$5.48 - $6.13

52 week range


$5.10 - $43.00

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Jan 29, 2024
8-k 8K-related 15 Dec 28, 2023
8-k 8K-related 14 Dec 21, 2023
3 Insider transactions 2 Dec 19, 2023
8-k 8K-related 14 Dec 13, 2023
4 Insider transactions 1 Dec 04, 2023
4 Insider transactions 1 Dec 04, 2023
8-k 8K-related 17 Nov 29, 2023
3 Insider transactions 1 Nov 29, 2023
3 Insider transactions 1 Nov 13, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.